| DRUGS APPROVED FDA approves first drug from Anacor Pharma FDA approves Beleodaq to treat rare, aggressive form of non-Hodgkin lymphoma Mylan Inc. (MYL) Launches Generic Micardis® Tablets |
 |
ADHD Meds May Double Cardiovascular Event Risk in Kids
Medscape Medical News - July 02, 2014
The use of psychostimulants in children and adolescents is associated with nearly twice the risk for a cardiovascular event compared with nonuse of the drugs, and the risk is even higher when the drugs are used for the treatment of attention-deficit/hyperactivity disorder (ADHD), new research suggests.
Latest Study Finds No Link Between Testosterone Supplements, Heart Attack
HealthDay News - July 2, 2014
Although recent research has linked testosterone therapy with a higher risk for heart attack and stroke, a new study involving more than 25,000 older men suggests otherwise.
Judge Blocks Massachusetts Painkiller Restriction
Associated Press - July 8, 2014
Massachusetts must temporarily suspend one of its key restrictions on Zohydro, a powerful new prescription painkiller, pending the outcome of a lawsuit challenging their constitutionality, a federal judge ruled on Tuesday.
FDA's Looming Decision On A Generic To Teva's Copaxone Reveals Drug Approval Woes
Forbes - July 7, 2014
A year ago, the Food and Drug Administration quietly posted a public notice that it wanted to hire an independent lab to test a generic drug that it had already approved. FDA wanted to make sure the drug was safe and effective.
'Remote control' contraceptive chip available 'by 2018'
BBC News - July 7, 2014
A contraceptive computer chip that can be controlled by remote control has been developed in Massachusetts. The chip would need replacing every 16 years.
Coalition Releases Report To Promote Safe Acetaminophen Use
Pain Medicine News - July 1, 2014
The Acetaminophen Awareness Coalition (AAC), an alliance of leading health, health care provider and consumer organizations, has released “Acetaminophen: How It’s Used, Preventing Overdose and What We Can Do to Promote Safe Use,” a report and an educational resource to promote safe and appropriate use of the most common drug ingredient in the United States.
California considering Rx mail-order opt-out law
Drug Topics - July 2, 2014
State lawmakers in California are considering a bill that would allow patients to opt out of health plan requirements that certain prescriptions be filled by mail order.
New Rules Allow Carry-Over of Flexible Health Funds
New York Times - July 4, 2014
IF your employer offers health care flexible spending accounts, you may have a new option for managing the funds.
Pharmacists say collaboration bill will improve care
The Topeka Capital-Journal - July 7, 2014
Kansas pharmacists say a bill that went into effect this past week will improve patient care by allowing them to enter into agreements with physicians to do things like monitor and change medication levels without new orders.
Google smartwatch is latest frontier for medication adherence app developer
MedCity News - July 8, 2014
Improving medication adherence has long been a priority for big pharma and healthcare providers, so it was interesting to see that of all the mobile health applications Google’s Smartwatch could have used, MediSafe became a priority for its wearables platform, too.
Rapid Price Increases for Some Generic Drugs Catch Users by Surprise
New York Times - July 8, 2014
The first sign of trouble came when Dr. Barry Lindenberg, a cardiologist, received a three-page insurance form in January, demanding he get preapproval to prescribe one of the oldest known heart medicines.
Critical Times for Small and Rural Hospitals
HealthLeaders Media - July 8, 2014
For healthcare facilities that serve an important niche, such as critical access hospitals, a variety of pressures are changing the way they do business.
Consumers Who Stick With Current Exchange Plans May Face Significant Premium Increases in 2015
Becker's Hospital Review - July 1, 2014
Consumers enrolled in exchange plans who receive federal assistance to reduce their monthly premiums may face substantial premium increases unless they switch insurance plans in 2015, according to a new study from Avalere Health.
With priority review, FDA could decide on Purdue Pharma’s abuse-deterrent painkiller by fall
MedCity News - July 8, 2014
US chronic pain specialist Purdue Pharma LP said Tuesday that its investigational once-daily, single-entity pain drug, hydrocodone bitartrate tablet (HYD), had obtained Priority Review status from the US FDA.
Industry calls on FDA to preserve INN drug identity practice for biosimilars
Drug Store News - July 2, 2014
As many as 32 organizations on Tuesday signed a letter calling on the Food and Drug Administration to require biologics and biosimilars to have the same International Nonproprietary Name, a practice currently in use in Europe and other markets.
Contact,
Kristin LaVitola
Marketing Director, PSG
Pharmaceutical Strategies Group (PSG)
Office: 972-244-8388
Email: KLavitola@PSGConsults.com
PSGNewsletter@PSGConsults.com
www.PSGConsults.com
 |
 |
 |